Trial no.:
|
PACTR201709002519185 |
Date of Approval:
|
14/08/2017 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
Efficacy of adipose derived stem cells in management of chronic ulcers: clinical and laboratory study |
Official scientific title |
Efficacy of adipose derived stem cells in management of chronic ulcers: clinical and laboratory study |
Brief summary describing the background
and objectives of the trial
|
Wound healing is an elaborate process that occurs in distinct, yet overlapping phases of well orchestrated cascade of biological and molecular processes: hemostasis, inflammation, proliferation and remodeling.
Chronic wounds occur when there is failure of injured skin to proceed through an orderly and timely process to produce anatomic and functional integrity.
Despite of the huge advances in medical care, chronic non-healing wounds still represent a challenge in our practice.
New therapies are required to optimize wound healing like cell therapies.
Cell therapy is defined as a set of strategies to use living cells as a regenerative therapy to repair, replace or restore biological function.
The term stem cells refers to a myriad of different cell types that share two key characteristics: Self-renewal and the potential for differentiation into different cell types and they are pleuripotent cells.
In 2001, Zuk et al. demonstrated that human fat obtained from human lipoaspirates contained multilineage stem cells, which have since been shown to have the potential to undergo adipogenesis, osteogenesis, chondrogenesis and myogenesis in vitro and in vivo.
Stem cells enhance cutaneous wound healing through trophic and paracrine activity.
The aim of using stem cells in wound healing is to increase the rates of healing whilst improving the quality of healing resulting in more of regenerative process rather than a repairing one.
|
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Chronic ulcers,Digestive System |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Drugs |
Anticipated trial start date |
06/09/2017 |
Actual trial start date |
06/09/2017 |
Anticipated date of last follow up |
06/09/2017 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
100 |
Actual target sample size (number of participants) |
|
Recruitment status |
Recruiting |
Publication URL |
|
|